Skip to content
Screener

Staar Surgical STAA Income Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
$93.54M+111%$93.52M+120%$57.8M+18.1%$94.73M+6.9%$44.32M-55.2%
$23.81M+107%$24.66M+69.1%$14.06M-18.7%$16.86M-16.1%$11.52M-44.1%
$69.73M+113%$68.86M+146%$43.74M+38.2%$77.88M+13.7%$32.8M-58.2%
74.5%+0.5pp73.6%+7.9pp75.7%+11.0pp82.2%+4.9pp74%-5.2pp
$9.94M-3.1%$9.93M-12.5%$9.24M-5.4%$9.21M-24.8%$10.26M-13.5%
$59.63M-5.0%$60.88M-28.7%$66.58M+11.8%$59.39M-5.4%$62.76M-5.6%
$26.94M+2.5%$24.51M-9.0%$25.84M-9.2%$23.46M-18.7%$26.28M-15.2%
$22.74M+8.4%$17.02M-30.4%$19.59M-8.2%$20.76M-4.3%$20.97M-11.3%
$10.1M+134%$7.98M+114%-$22.84M+18.2%$18.49M+225%-$29.96M-352%
10.8%+78.4pp8.5%+143pp-39.5%+17.5pp19.5%+13.1pp-67.6%-79.6pp
$939K-31.3%$907K-33.6%$1.07M-31.0%$790K-43.9%$1.37M-3.9%
$923K-77.2%$239K-91.8%$2.19M$300K-96.0%$4.05M+359%
$11.02M+143%$8.22M+115%-$20.65M+31.9%$18.79M+42.8%-$25.92M-351%
$2.97M+133%$3.01M+1,195%-$2.34M-160%$9.91M+212%-$9.1M-408%
$8.06M+148%$5.21M+110%-$18.31M+46.5%$8.88M-11.0%-$16.81M-328%
8.6%+46.5pp5.6%+133pp-31.7%+38.2pp9.4%-1.9pp-37.9%-45.4pp
$0.16+147%$0.10+109%-$0.36+47.8%$0.18-10.0%-$0.34-327%
$12.49M+145%$10.09M+118%-$20.83M+18.4%$20.49M+175%-$27.99M-309%
13.4%+76.5pp10.8%+140pp-36%+16.1pp21.6%+13.2pp-63.2%-76.7pp
$10.1M+134%$7.98M+114%-$22.84M+18.2%$18.49M+225%-$29.96M-352%

FAQ

What is Staar Surgical's revenue?
Staar Surgical (STAA) generated $339.6M in revenue over the trailing twelve months, up 51.3% year over year.
Is Staar Surgical profitable?
Staar Surgical reported $3.8M in net income over the trailing twelve months, a 1.1% net margin.
What are Staar Surgical's profit margins?
Gross margin is 76.6% and operating margin is 4.0%, with a 1.1% net margin.
What is Staar Surgical's earnings per share?
Staar Surgical's diluted EPS over the trailing twelve months is $0.08.
Where does Staar Surgical's income statement data come from?
Every line is extracted from Staar Surgical's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.